Mitomycin C 40mg Injection
Marketer
Biochem Pharmaceutical Industries
Salt Composition
Mitomycin (40mg)
Overview Mitomycin C 40mg Injection
Pancreatic, breast, lung, and stomach cancers may be treated with a 40mg Mitomycin C injection. Administered intravenously under medical supervision, this medication can be used alone or as part of a combination chemotherapy regimen. Its mechanism involves disrupting cancerous cell growth, leading to their destruction. Dosage and frequency are determined by your physician based on your specific condition and may adjust over time; strict adherence to the prescribed regimen is crucial to avoid severe adverse reactions. While therapeutic effects might not be immediately apparent, discontinue use only upon your doctor's instruction. Common side effects include anemia, leukopenia, increased bleeding risk, anorexia, nausea, and vomiting; report any concerning symptoms promptly. Pre-treatment disclosure of any blood, kidney, liver, or respiratory issues is essential. This medication lowers blood cell counts, raising infection susceptibility. Regular blood tests to monitor blood cell levels, kidney, liver, and heart function are mandatory throughout treatment. Both partners should utilize effective contraception during treatment to prevent pregnancy.
Uses of Mitomycin C 40mg Injection
Malignancies of the pancreas, breast, lung (non-small cell), and stomach.
Major Benefits of Mitomycin C 40mg Injection:
This medication will be administered by your physician or their qualified nurse. Self-medication is strictly prohibited.
Common Side effects of Mitomycin C 40mg Injection:
- Anemia (low number of red blood cells)
- Decreased white blood cell count
- Increased bleeding tendency
- Loss of appetite
- Nausea
- Vomiting
- Feeling of discomfort
- Low blood platelets
- Weight loss
- Rash
How to use Mitomycin C 40mg Injection:
This medication will be administered by your healthcare provider; self-medication is strongly discouraged.
How Mitomycin C 40mg Injection works:
Mitomycin C 40mg injectable solution is a chemotherapeutic agent. Its mechanism of action involves DNA disruption within cancerous cells, thereby inhibiting their proliferation and growth.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Mitomycin C 40mg Injection and alcohol can lead to increased sleepiness.
PregnancyUNSAFE
Administering Mitomycin C 40mg Injection to pregnant individuals is strongly contraindicated. Pregnant women should consult their physician; research in animal models and human studies reveals substantial risks to the fetus.
Breast feedingCAUTION
The administration of 40mg Mitomycin C injections necessitates careful consideration in breastfeeding mothers. Lactation should be discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Mitomycin C 40mg Injection may induce adverse reactions that compromise driving capabilities. Nausea and vomiting, potential side effects of this injection, can significantly slow reflexes, rendering safe operation of a motor vehicle unsafe.
KidneyCAUTION
Patients with impaired kidney function should receive Mitomycin C 40mg Injection cautiously, potentially requiring dose modification. Consultation with a physician is advised. Mitomycin C 40mg Injection is contraindicated in individuals with terminal kidney failure.
LiverCAUTION
Patients with liver impairment should receive Mitomycin C 40mg Injection cautiously, potentially requiring a modified dosage. Medical advice is necessary. Mitomycin C 40mg Injection may be unsuitable for certain individuals with liver dysfunction.
What if you forget to take Mitomycin C 40mg Injection :
NA
Facts to Know About Mitomycin C 40mg Injection
| Label | Value |
|---|---|
| Type of Compound | Cancer-fighting antibiotics |
| Potential for Dependence | None. |
| Type of Treatment | Cancer therapeutics |
| Mechanism of Action | Plant-derived anti-cancer compounds |
3,018 People bought this recently